These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10699473)

  • 41. [Cancer of the tonsillar region. Role of irradiation in treatment].
    Calais G; Chauvet B; Garand G; Beutter P; Reynaud-Bougnoux A; Le Floch O
    Ann Radiol (Paris); 1989; 32(7-8):555-9. PubMed ID: 2633687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction of radiation-induced xerostomia in nasopharyngeal carcinoma using CT simulation with laser patient marking and three-field irradiation technique.
    Nishioka T; Shirato H; Arimoto T; Kaneko M; Kitahara T; Oomori K; Yasuda M; Fukuda S; Inuyama Y; Miyasaka K
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):705-12. PubMed ID: 9240636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: a retrospective analysis of the radiumhemmet data, 1980-1995.
    Friesland S; Fernberg JO; Lundell G; Munck-Wikland E; Strander H; Lewensohn R
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1259-66. PubMed ID: 10613321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carcinoma of the soft palate treated with irradiation: analysis of results and complications.
    Amdur RJ; Mendenhall WM; Parsons JT; Isaacs JH; Million RR; Cassisi NJ
    Radiother Oncol; 1987 Jul; 9(3):185-94. PubMed ID: 3628855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later.
    Huang SH; Waldron J; Bratman SV; Su J; Kim J; Bayley A; Cho J; Giuliani M; Hope A; Ringash J; Hansen A; de Almeida JR; Goldstein D; Perez-Ordonez B; Weinreb I; Tong L; Xu W; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):159-169. PubMed ID: 28258895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy.
    Vergeer MR; Doornaert PA; Jonkman A; Kaanders JH; van den Ende PL; de Jong MA; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):682-8. PubMed ID: 20188492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia?
    You SH; Kim SY; Lee CG; Keum KC; Kim JH; Lee IJ; Kim YB; Koom WS; Cho J; Kim SK; Kim GE
    Am J Clin Oncol; 2012 Jun; 35(3):261-6. PubMed ID: 21383607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interstitial and external radiotherapy in carcinoma of the soft palate and uvula.
    Esche BA; Haie CM; Gerbaulet AP; Eschwege F; Richard JM; Chassagne D
    Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):619-25. PubMed ID: 3138213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Velotonsillar squamous cell carcinoma: 277 cases treated by combined external irradiation and brachytherapy--results according to extension, localization, and dose rate.
    Pernot M; Malissard L; Taghian A; Hoffstetter S; Luporsi E; Forçard JJ; Aletti P; Bey P
    Int J Radiat Oncol Biol Phys; 1992; 23(4):715-23. PubMed ID: 1618663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tonsillar cancer: the Peter MacCallum experience with unilateral and bilateral irradiation.
    Liu C; Dutu G; Peters LJ; Rischin D; Corry J
    Head Neck; 2014 Mar; 36(3):317-22. PubMed ID: 23729387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy.
    Mourad WF; Hu KS; Puckett L; Hauerstock D; Shourbaji RA; Li Z; Manolidis S; Schantz S; Tran T; Jacobson A; Urken M; Culliney B; Persky M; Harrison LB
    Am J Clin Oncol; 2014 Feb; 37(1):57-62. PubMed ID: 23357967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate.
    Nijdam W; Levendag P; Noever I; Uyl-de Groot C; van Agthoven M
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):488-94. PubMed ID: 15145167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Definitive radiotherapy for tonsillar squamous cell carcinoma.
    Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Malyapa RS; Werning JW; Lansford CD; Villaret DB
    Am J Clin Oncol; 2006 Jun; 29(3):290-7. PubMed ID: 16755183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer.
    Cannon DM; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):660-5. PubMed ID: 18037580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Results of irradiation in squamous cell carcinoma of the soft palate and uvula.
    Keus RB; Pontvert D; Brunin F; Jaulerry C; Bataini JP
    Radiother Oncol; 1988 Apr; 11(4):311-7. PubMed ID: 3131842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantification of trade-off between parotid gland sparing and planning target volume underdosages in clinically node-negative head-and-neck intensity-modulated radiotherapy.
    de Kruijf WJ; Heijmen BJ; Levendag PC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):136-43. PubMed ID: 17276611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiation therapy for squamous cell carcinoma of the tonsil.
    Foote RL; Hilgenfeld RU; Kunselman SJ; Schaid DJ; Buskirk SJ; Grado GL; Earle JD
    Mayo Clin Proc; 1994 Jun; 69(6):525-31. PubMed ID: 8189757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant radiation in the TORS era: Is there a benefit to omitting the tumor bed?
    Lazarev S; Todorov B; Tam J; Gupta V; Miles BA; Lee N; Bakst RL
    Pract Radiat Oncol; 2017; 7(2):93-99. PubMed ID: 28274400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.